Results 11 to 20 of about 475,202 (310)

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study [PDF]

, 2013
We determined whether any individual cancers are increased or decreased in a cohort of 595 patients with systemic lupus erythematosus (SLE) followed for up to 32 years at the University College London Hospitals Lupus Clinic, looking for any associated ...
Dey, D, Isenberg, DA, Kenu, E
core   +1 more source

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis

RMD Open, 2019
Introduction Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitis with distinct pathophysiological mechanisms, clinical features and treatment responses.
David Jayne, Rachel B Jones, Vítor Teixeira, Aladdin J Mohammad, Rona Smith   +4 more
doaj   +1 more source

Ann Rheum Dis [PDF]

, 2011
Objective This study was conducted with sera from patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and arthritis and lupus-like disease animal models to identify innate immune system-dependent and -independent ...
Burmester, G., Häupl, T., Konthur, Z., Marklein, B., Shlomchik, M., Skriner, K.   +5 more
core   +2 more sources

Squeezed between shells? On the origin of the Lupus I molecular cloud. - II. APEX CO and GASS HI observations [PDF]

, 2017
Accepted for publication in a future issue of Astronomy & Astrophysics. Reproduced with permission from Astronomy & Astrophysics. © 2018 ESO.Context. The Lupus I cloud is found between the Upper-Scorpius (USco) and the Upper-Centaurus-Lupus (UCL) sub ...
A. Burkert, B. Gaczkowski, Benedettini, Benedettini, Bergin, Bouy, Calderón, Carlhoff, Clark, D. Kröll, Dawson, de Geus, de Zeeuw, Deharveng, Elmegreen, Gaczkowski, Goldsmith, Güsten, Hacar, Hara, Hartmann, Haworth, Heiner, Heitsch, J. Ngoumou, K. Fierlinger, Kalberla, Kalberla, Koyama, Krause, Ladd, M. G. H. Krause, Mangum, Matsumoto, Matthews, Motte, Myers, Myers, Ntormousi, Palmeirim, Phillips, Preibisch, Pöppel, R. Diehl, S. Flaischlen, T. Preibisch, Tachihara, Tachihara, Thompson, Tothill, V. Roccatagliata, Vassilev, Vilas-Boas, Vishniac, Vázquez-Semadeni, Walch, Welsh, Whitworth, Wilson   +58 more
core   +3 more sources

Lupus erythematosus

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2023
SummaryCutaneous lupus erythematosus can manifest with or without systemic involvement resulting in a broad clinical spectrum. Disease pathogenesis is often characterized by a loss of tolerance to endogenous antigens and a chronic relapsing activation of the innate and adaptive immune system.
Günther, Claudia, Wenzel, Jörg
openaire   +3 more sources

Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety

Lupus Science and Medicine, 2021
Objective To report the results of a survey exploring the experience of patients with SLE facing hydroxychloroquine (HCQ) shortage that occurred during the early phases of the COVID-19 pandemic.Methods A survey was designed by Lupus Europe’s patient ...
Alain Cornet, Chiara Tani, Marta Mosca, Jeanette Andersen   +3 more
doaj   +1 more source

Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice [PDF]

, 2019
Epoxy-fatty-acids (EpFAs), cytochrome P450 dependent arachidonic acid derivatives, have been suggested to have anti-inflammatory properties, though their effects on autoimmune diseases like systemic lupus erythematosus (SLE) have yet to be investigated ...
Dragun, Duska, Enghard, Philipp, Gollasch, Maik, Hammock, Bruce D., Klocke, Jan, Riemekasten, Gabriela, Rudolph, Birgit, Schunck, Wolf-Hagen, Ulu, Arzu, Wu, Kaiyin   +9 more
core   +2 more sources

Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio

Reumatismo, 2015
Joint involvement is a common manifestation in systemic lupus erythematosus (SLE). According to the SLE disease activity index 2000 (SLEDAI-2K), joint involvement is present in case of ≥2 joints with pain and signs of inflammation.
E. Cipriano, F. Ceccarelli, L. Massaro, F. R. Spinelli, C. Alessandri, C. Perricone, G. Valesini, F. Conti   +7 more
doaj   +1 more source

Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial. [PDF]

, 2019
BackgroundTreatment decision-making regarding immunosuppressive therapy is challenging for individuals with lupus. We assessed the effectiveness of a decision aid for immunosuppressive therapy in lupus nephritis.Methods and findingsIn a United States ...
Alarcón, Graciela S, Barton, Jennifer L, Caro, Brennda, Chatham, W Winn, Dall'Era, Maria, Eakin, Guy S, Fraenkel, Liana, Garcia, Salvador R, Green, Candace, Grossman, Jennifer, Hanrahan, Leslie M, Jandali, Bochra, Kimberly, Robert P, Leong, Amye L, Marrow, Laura, Meara, Alexa, Morgan, Charity J, Raymond, Sandra C, Reyes, Elyse, Rizvi, Tara, Saag, Kenneth G, Singh, Jasvinder A, Sloan, Jeffrey A, Street, Richard L, Suarez-Almazor, Maria E, Trupin, Laura, Winthrop, Kevin L, Yazdany, Jinoos   +27 more
core   +2 more sources

Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus

Arthritis Research & Therapy, 2018
Background The application of more sensitive imaging techniques, such as ultrasonography (US), changed the concept of non-erosive arthritis in systemic lupus erythematosus (SLE), underlining the need for biomarkers to identify patients developing the ...
Fulvia Ceccarelli, Carlo Perricone, Tania Colasanti, Laura Massaro, Enrica Cipriano, Monica Pendolino, Francesco Natalucci, Riccardo Mancini, Francesca Romana Spinelli, Guido Valesini, Fabrizio Conti, Cristiano Alessandri   +11 more
doaj   +1 more source